NCT00979758.

Trial name or title	Strengthening transplantation effects of bone marrow mononuclear cells with atorvastatin in myocardial infarction
Methods	Type of study: parallel RCT Source of funding: not reported Country of origin: China Number of centres: 1 Intended enrolment: 100
Participants	Population: STEMI Age, mean (SD) each arm: not reported (30 to 80 years) Sex, % male in each arm: not reported Number of diseased vessels: not reported Number of stunned hyperkinetic, etc segments: not reported Time from symptom onset to initial treatment: not reported Statistically significant baseline imbalances between the groups? not reported
Interventions	Intervention arm: BMSC + Artovastatin (routine or intensive dose) Type of stem cells: BMSC (mononuclear cells) Summary of how stem cells were isolated and type and route of delivery: bone marrow aspirated, preparation of media, delivery via intracoronary injection Dose of stem cells: not reported Timing of stem cell procedure: not reported Comparator arm: atorvastatin (routine or intensive dose)
Outcomes	Primary outcomes: LVEF Secondary outcomes: not reported Outcome assessment points: baseline and 12 months Method(s): ECG, echocardiography, MRI
Starting date	January 2009
Contact information	Fuwai Hospital, Beijing, China, 100037; Lead: Dr Yang Yuejin
Notes	Estimated study completion date: January 2012. This study is enrolling participants by invitation only